Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Gynaecological Cancers Congress 2023

GSK - Shifting the treatment paradigm of OC/EC: Towards a new horizon

Where are we going with EC? Aiming to improve outcomes in primary advanced or recurrent endometrial cancer with PD-(L)1 inhibitors

Date

23 Feb 2023

Session

GSK - Shifting the treatment paradigm of OC/EC: Towards a new horizon

Topics

Tumour Site

Endometrial Cancer

Presenters

Ainhoa Madariaga Urrutia

Authors

A. Madariaga Urrutia

Author affiliations

  • Hospital Universitario 12 de Octubre, Madrid/ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Live Q&A and discussion

Presenter: All Speakers

Session: GSK - Shifting the treatment paradigm of OC/EC: Towards a new horizon

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.